Palvella Therapeutics, Inc. Public Float
Palvella Therapeutics, Inc. (PVLA) had Public Float of $196.70 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $196.70M.
- 2024-06-28: Entity Public Float $9.20M.
- 2023-06-30: Entity Public Float $11.22M.
- 2022-06-30: Entity Public Float $114.09M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $196.70M 10-K · filed 2026-03-31 |
| 2024-06-28 | $9.20M 10-K · filed 2025-03-31 |
| 2023-06-30 | $11.22M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $114.09M 10-K · filed 2023-03-31 |
| 2021-06-30 | $170.61M 10-K/A · filed 2022-07-06 |
| 2020-06-30 | $117.42M 10-K · filed 2021-03-31 |
| 2019-06-28 | $206.30M 10-K · filed 2020-03-13 |
| 2018-06-29 | $273.28M 10-K · filed 2019-03-18 |
| 2017-06-30 | $184.96M 10-K · filed 2018-03-15 |
| 2016-06-30 | $69.32M 10-K · filed 2017-03-30 |
| 2015-06-30 | $62.34M 10-K · filed 2016-03-23 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 |
| 2014-06-30 | $0.00 10-K · filed 2015-03-30 |
| 2014-03-31 | $0.00 10-Q · filed 2014-06-02 |
| 2013-12-31 | $0.00 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |